期刊
SCIENCE
卷 379, 期 6630, 页码 351-357出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.ade3332
关键词
-
We have characterized the molecular mode of action of biguanides by studying the drug-target interaction with cryo-electron microscopy and enzyme kinetics. Our results explain the selectivity of biguanide binding to different enzyme states and provide a structural basis for their action. This research also opens new opportunities for the rational design of medicinal biguanides.
The molecular mode of action of biguanides, including the drug metformin, which is widely used in the treatment of diabetes, is incompletely characterized. Here, we define the inhibitory drug-target interaction(s) of a model biguanide with mammalian respiratory complex I by combining cryo-electron microscopy and enzyme kinetics. We interpret these data to explain the selectivity of biguanide binding to different enzyme states. The primary inhibitory site is in an amphipathic region of the quinone-binding channel, and an additional binding site is in a pocket on the intermembrane-space side of the enzyme. An independent local chaotropic interaction, not previously described for any drug, displaces a portion of a key helix in the membrane domain. Our data provide a structural basis for biguanide action and enable the rational design of medicinal biguanides.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据